Literature DB >> 7086709

Radioiodination of parasite antigens with 1,3,4,6-tetrachloro-3 alpha, 6 alpha-diphenylglycoluril (IODOGEN): studies with zygotes of Plasmodium gallinaceum.

R J Howard, D C Kaushal, R Carter.   

Abstract

The iodinating reagent 1,3,4,6-tetrachloro-3 alpha, 6 alpha-diphenylglycoluril (IODOGEN) was used to label antigens on zygotes of Plasmodium gallinaceum with parallel studies using lactoperoxidase-catalyzed radioiodination for comparison. Proteins labeled by the IODOGEN method are most probably on the surface of the zygote, as the pattern of labeled proteins analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis was very similar to the pattern of lactoperoxidase-labeled proteins. Furthermore, the labeled proteins represented only a subset of the total Coomassie Blue-stained proteins. The radioiodinated zygote proteins were immunoreactive after IODOGEN or lactoperoxidase labeling. The IODOGEN method is technically much more simple than the lactoperoxidase method and does not require the addition of extraneous proteins or H2O2. The advantages of IODOGEN labeling, together with the essential equivalence of results obtained by these two methods, make the IODOGEN method attractive for labeling parasite antigens in general.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7086709     DOI: 10.1111/j.1550-7408.1982.tb02891.x

Source DB:  PubMed          Journal:  J Protozool        ISSN: 0022-3921


  14 in total

1.  A biochemical and immunological comparative study on Trypanosoma equiperdum and Trypanosoma evansi.

Authors:  S Giardina; G Paganico; G Urbani; M Rossi
Journal:  Vet Res Commun       Date:  2003-05       Impact factor: 2.459

2.  Identification and biochemical characterization of antigens of tachyzoites and bradyzoites of Toxoplasma gondii with cross-reactive epitopes.

Authors:  F Darcy; H Charif; H Caron; D Deslée; R J Pierce; M F Cesbron-Delauw; A Decoster; A Capron
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

3.  Identification of a continuous and cross-reacting epitope for Plasmodium falciparum transmission-blocking immunity.

Authors:  B Wizel; N Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

4.  Identification and isolation of a major cell surface glycoprotein of Pneumocystis carinii.

Authors:  J A Radding; M Y Armstrong; E Ullu; F F Richards
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

5.  Characterization of Leishmania major antigen-liposomes that protect BALB/c mice against cutaneous leishmaniasis.

Authors:  L P Kahl; R Lelchuk; C A Scott; J Beesley
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

6.  Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230.

Authors:  J Healer; D McGuinness; P Hopcroft; S Haley; R Carter; E Riley
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

7.  Subspecies-specific surface antigens of promastigotes of the Leishmania donovani complex.

Authors:  J L Lemesre; F S Rizvi; D Afchain; M Sadigursky; A Capron; F Santoro
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

8.  Biochemical and immunological characterization of major surface antigens of Sarcocystis muris and S. suicanis cyst merozoites.

Authors:  I Sommer; H Mehlhorn; W Rüger
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

9.  Characterization and immunoprotective properties of a monoclonal antibody against the major oocyst wall protein of Eimeria tenella.

Authors:  M J Karim; S C Basak; A J Trees
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

10.  Recognition of Toxoplasma gondii excreted and secreted antigens by human sera from acquired and congenital toxoplasmosis: identification of markers of acute and chronic infection.

Authors:  A Decoster; F Darcy; A Capron
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.